3 completed, 2 unknown, 1 active not recruiting, 1 enrolling by invitation. 3 Not applicable, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Color: new trials by email Literature Review of Color trials Research Report on Color
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating How Well Different Types of Light-sensitive Cells in the Eye Contribute to Its Focusing Ability Color - Monochromatic, L- and S-cone Modulation Only | Not applicable | Recruiting | Rochester Institute of Technology | 20 | 2026-07-02 | 2026-07-17 |
| Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients Participants will receive Tongmai Jiangtang Capsule (TJC) in addition to standard treatment., A placebo capsule that is identical in appearance, size, color, formulation, weight, taste, and smell to TJC - Metabolic Syndrome, Cardiovascular Disease (CKD) | Phase 3 | Enrolling by invitation | Guangdong Provincial Hospital of Traditional Chinese Medicine | 530 | 2025-04-24 | 2025-06-13 |
| Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk for Nausea and Vomiting Undergoing Gynecological Surgery Encapsulated amisulpride 50 mg (matched for color, weight, smell and size), Encapsulated placebo (matched for color, weight, smell and size) - Post Operative Nausea and Vomiting (PONV) | Phase 2 | Active not recruiting | Instituto do Cancer do Estado de São Paulo | 276 | 2025-04-10 | 2026-09-09 |
| Multimodal Imaging in Vitreo-retinal Surgery and Macular Dystrophies Biometry, Retinography (Color) + Autofluorescence (AF), OCT B-scan and OCT angiography (OCTA) - Macular Holes, Epiretinal Membrane | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 100 | 2021-01-15 | 2024-02-13 | |
| Using Video Gaming to Evaluate Front of Pack Labeling With Children Four FOP label designs - Child Obesity | Not applicable | Completed | Michigan State University | 80 | 2016-02-02 | 2018-03-29 |
| Promoting Healthier Food Purchases By Leveraging the Online-Grocery Environment Nutrition facts automatically or not automatically displayed, Nutrition facts in color, Nutrition Facts Label in Larger Font - Obesity | Unknown | University of Vermont | 400 | 2015-08-01 | 2018-05-03 | |
| Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence Motivational Enhancement/Cognitive Behavioral Therapy, Sativex, Placebo spray - Cannabis Dependence | Phase 2 | Completed | Centre for Addiction and Mental Health | 45 | 2013-03-01 | 2017-10-02 |
| Fixed or Self-Titrated Dosages of Sativex on Cannabis Users Sativex, Placebo - Cannabis Dependence | Not applicable | Completed | Centre for Addiction and Mental Health | 16 | 2013-02-01 | 2016-02-01 |
Marijuana Abuse (2) · Cardiovascular Diseases (1) · Cerebrovascular Disorders (1) · Epiretinal Membrane (1) · Macular Degeneration (1) · Metabolic Syndrome (1) · Obesity (1) · Pediatric Obesity (1) · Postoperative Nausea and Vomiting (1) · Retinal Detachment (1) · Retinal Perforations (1) · Vomiting (1)
Centre for Addiction and Mental Health (2) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Guangdong Provincial Hospital of Traditional Chinese Medicine (1) · Instituto do Cancer do Estado de São Paulo (1) · Michigan State University (1) · Rochester Institute of Technology (1) · University of Vermont (1)
United States (3) · Canada (2) · Brazil (1) · China (1) · Italy (1)
Angela M Sousa, MD, MsC, PhD (1) · Bernard Le Foll (1) · Bernard Le Foll, MD, PhD (1) · Mark Becker, PhD (1)
PMID 24176437, PMID 37692969, PMID 38719346, PMID 42582064
R00EY036497 (1), R21DA031906 (1)